InvestorsHub Logo
Followers 24
Posts 3145
Boards Moderated 0
Alias Born 07/30/2009

Re: JG36 post# 79238

Wednesday, 01/29/2014 6:59:42 AM

Wednesday, January 29, 2014 6:59:42 AM

Post# of 146240
Totally wrong. As is so often the case with your statements that one was based on a gross generality with no reference whatsoever to the specifics of NNVC that indicate why the generality is inapplicable.

Almost all generalities have exceptions and many are crude ones that are not all that accurate even when applied to a group **as a whole**. They are only useful at all when applied to **groups** and are often totally wrong when applied to individual cases. You can readily drown crossing a river that's only 18 inches deep. Get it? It's the deviations from the average that are the most important.

NNVC has many factors that strongly support the claim of 90% probability of success and they've been discussed here very frequently and in great detail. Yet you blithely ignore all of it in favor of a gross generality that clearly does not apply.

Very brieflly:

all current anti virals are of both very limited efficacy and of narrow applicability.

NNVC's drugs are, by the nature of their design both highly effective (traps the virus with a receptor that the virus cannot avoid because it MUST use that receptor to infect and the same receptors are used by whole classes of viruses, making the drugs broadly applicable).

I'm really not at all sure how you manage to overlook that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News